Jacobs receives contract to provide information technology services to NIH

NewsGuard 100/100 Score
Jacobs Engineering Group Inc. (NYSE: JEC) announced that it has been awarded a contract to provide information technology services to the National Institutes of Health (NIH) and certain other government agencies.

This multiple award, indefinite delivery/indefinite quantity (IDIQ) contract has a maximum order limit of $20 billion over a period of ten years.

Under the terms of the contract, the scope of work for this effort includes Chief Information Officer support; IT services for biomedical research, health sciences and healthcare; IT operations and maintenance; integration services; critical infrastructure protection and information assurance; digital government; enterprise resource planning; clinical support, resources and studies; software development; imaging; and outsourcing.

In making the announcement, Jacobs Group Vice President Robert Norfleet stated, "We are pleased to continue our support for the Institutes and Centers of the NIH and the Department of Health and Human Services to provide a broad range of IT capabilities, solutions and services to the healthcare industry."

SOURCE Jacobs Engineering Group Inc

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses